Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.42 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.42 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | STAT6 | P42226 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.42 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL4085700 | 0.78 | PI4KA (0.58) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Ribose (Furanose) SCHEMBL4079014 | 0.78 | PI4KA (0.58) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| SCHEMBL11362 | 0.77 | PI4KA (0.45) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| Ribose (Furanose) SCHEMBL5576201 | 0.76 | ADK (0.49) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Ribose (Furanose) SCHEMBL4077631 | 0.76 | ADK (0.49) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Adenine SCHEMBL7746165 | 0.75 | PI4KA (0.58) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Adenine SCHEMBL580228 | 0.75 | PI4KA (0.58) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Adenine SCHEMBL38386 | 0.75 | PI4KA (0.58) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Adenine SCHEMBL7624128 | 0.75 | PI4KA (0.58) | HIF1ADOT1LSMN1; SMN2ADORA3DPP4 | |
| Hydrochloric Acid SCHEMBL14742344 | 0.75 | PI4KA (0.44) | ADORA2AADORA1PI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7491818-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2009-02-17 | — | — | US | disclosed |
| US-7423143-B2 | Nucleic acid labeling compounds | AFFYMETRIX. INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-7291463-B2 | Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis | AFFYMETRIX, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| US-7282327-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7179905-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-20050287563-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2005-12-29 | — | — | US | disclosed |
| US-6965020-B2 | Nucleic acid labeling compounds | AFFYMETRIX, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| EP-1589025-A2 | Nucleic acid labeling compounds | Affymetrix, Inc. (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20050164268-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2005-07-28 | — | — | US | disclosed |
| EP-1124838-B1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2005-06-01 | — | — | EP | disclosed |
| US-20040002595-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2004-01-01 | — | — | US | disclosed |
| US-20030232979-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2003-12-18 | — | — | US | disclosed |
| US-20030180757-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2003-09-25 | — | — | US | disclosed |
| US-6596856-B2 | For probes, comprising a heterocycle condensed with a cyclic group such as ribofuranose derivative; biotin and 5-carboxyfluorescein derivatives | AFFYMETRIX, INC. | 2003-07-22 | — | — | US | disclosed |
| US-20020165372-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2002-11-07 | — | — | US | disclosed |
| WO-2000006771-A9 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX INC (US) | 2002-08-22 | — | — | WO | disclosed |
| US-20010044531-A1 | Nucleic acid labeling compounds | AFFYMETRIX, INC. | 2001-11-22 | — | — | US | disclosed |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. | 2001-08-30 | — | — | US | disclosed |
| EP-1124838-A2 | NUCLEIC ACID LABELING COMPOUNDS | Affymetrix, Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000006771-A2 | NUCLEIC ACID LABELING COMPOUNDS | AFFYMETRIX, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040002595-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20030180757-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20050164268-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20010044531-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20050287563-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20010018514-A1 | NUCLEIC ACID LABELING COMPOUNDS | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20020165372-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
| US-20030232979-A1 | Nucleic acid labeling compounds | RNGTT, DUT, FBL | HIF1A 2889/4885DOT1L 955/4885SMN1; SMN2 1926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.